Table 3.
Clinical characteristics | Cases | Controls | p valuea |
---|---|---|---|
(80 cases) | (160 cases) | ||
Male (%) | 39 (48.8) | 78 (48.8) | 1.000 |
Age > = 65 years old (%) | 36 (45.0) | 40 (25.0) | 0.002 |
Length of hospital stay > = 30 days (%) | 25 (31.3) | 36 (22.5) | 0.158 |
Surgery (%) | 57 (71.2) | 83 (51.9) | 0.005 |
Central venous catheters >7 days (%) | 63 (78.8) | 95 (59.4) | 0.003 |
Total parenteral nutrition >5 days (%) | 48 (60.0) | 23 (18.1) | <0.001 |
Urinary catheter >2 days (%) | 61 (76.2) | 59 (36.9) | <0.001 |
Nasogastric tube >3 days (%) | 44 (55.0) | 39 (24.4) | <0.001 |
Mechanical ventilation >2 days (%) | 8 (10.0) | 7 (4.4) | 0.098 |
Neutropenia (%) | 11 (13.8) | 24 (15.0) | 0.849 |
Chemotherapy (%) | 46 (57.5) | 100 (62.5) | 0.271 |
Distant organ metastasis of cancer (%) | 32 (40.0) | 27 (16.9) | <0.001 |
Gastrointestinal cancer (%) | 41 (51.3) | 30 (18.8) | <0.001 |
ICU admitted >3 days (%) | 18 (22.5) | 25 (15.6) | 0.213 |
Medicine ward (%) | 13 (16.2) | 50 (31.2) | 0.013 |
Surgery ward (%) | 49 (61.3) | 85 (53.1) | 0.271 |
Previous antibiotics exposure (%) | 75 (93.8) | 130 (81.3) | 0.011 |
ICU intensive care unit
aFisher’s exact test